PCC 2.22% 22.0¢ probiomics limited

re: new tc report They are not a bad specy buy, but there's a...

  1. 11,720 Posts.
    lightbulb Created with Sketch. 1695
    re: new tc report They are not a bad specy buy, but there's a lot of risk. It just doesn't seem worth it to me atm, when there's so much upward potential with co's like acl, with so little risk. Why risk your money on pcc, when there are safer stocks elsewhere?
 
watchlist Created with Sketch. Add PCC (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.